Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
First Appeared on 5/14/2017
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|HPV4: HPV (GARDASIL) / MERCK & CO. INC.||- / 0||UN / IM|
Administered by: Other Purchased by: Other
Symptoms: Dysuria, Eczema, Fatigue, Headache, Cognitive disorder, Orthostatic intolerance
Life Threatening? No
Permanent Disability? Yes
ER or Doctor Visit? No
Other Medications: No other medications
Current Illness: HPV immunisation
Diagnostic Lab Data:
CDC 'Split Type': WAES1512DNK011219
Write-up:Information has been received from SPMSD (case report # DK-1577272925-2015001195) on 21-DEC-2015. Case received from a physician on 17-Dec-2015. A female patient of unknown age received GARDASIL, (batch/lot number and expiration date unknown) via intramuscular route in 2010. The patient experienced Headache in 2010, Orthostatic intolerance on an unknown date, Voiding difficulty on an unknown date, Eczema on an unknown date, Fatigue extreme on an unknown date and Cognitive dysfunction on an unknown date. Shortly after her first and only dose of GARDASIL, the patient develops headache and since then the other reported symptoms develop. The patient cannot remember vaccination dates, but believes it was in 2010 and remember that the headache came shortly after.
Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166